» Articles » PMID: 29431075

The Role of Forkhead Box 1 (FOXO1) in the Immune System: Dendritic Cells, T Cells, B Cells, and Hematopoietic Stem Cells

Overview
Publisher Begell House
Date 2018 Feb 13
PMID 29431075
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Forkhead box-O (FOXO) transcription factors have a fundamental role in the development and differentiation of immune cells. FOXO1 and FOXO3 are FOXO members that are structurally similar and bind to the same conserved consensus DNA sequences to induce transcription. FOXO1 has been studied in detail in the activation of dendritic cells (DCs), where it plays an important role through the regulation of target genes such as ICAM-1, CCR7, and the integrin αvβ3. FOXO1 is activated by bacteria challenge in DCs and promotes DC bacterial phagocytosis, migration, homing to lymph nodes, DC stimulation of CD4+ T cells and resting B cells, and antibody production. Deletion of FOXO1 in DCs enhances susceptibility to bacteria-induced periodontal disease. FOXO1 and FOXO3 maintain naive T cell quiescence and survival. FOXO1 and FOXO3 enhance the formation of regulatory T cells and inhibit the formation of T-helper 1 (Th1) and Th17 cells. FOXO1 promotes differentiation, proliferation, survival, immunoglobulin gene rearrangement, and class switching in B cells, but FOXO3 has little effect. Both FOXO1 and FOXO3 are important in the maintenance of hematopoietic stem cells by protecting them from oxidative stress. This review examines FOXO1/FOXO3 in the adaptive immune response, key target genes, and FOXO inhibition by the phosphoinositide 3-kinase/AKT pathway.

Citing Articles

Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approach.

Imran M, Altamimi A, Afzal M, Babu M, Goyal K, Ballal S Biogerontology. 2025; 26(1):45.

PMID: 39831933 DOI: 10.1007/s10522-025-10189-z.


Epigenetic Drift Is Involved in the Efficacy of HBV Vaccination.

Ferraresi F, Anticoli S, Salvioli S, Pirazzini C, Calzari L, Gentilini D Vaccines (Basel). 2025; 12(12.

PMID: 39771992 PMC: 11680278. DOI: 10.3390/vaccines12121330.


miR-132-3p downregulates in CD4 T cells and is associated with disease manifestations in patients with lupus.

Qin H, Chen S, Liu X, Liang J, Wu H, Zhu X J Int Med Res. 2024; 52(10):3000605241286762.

PMID: 39429035 PMC: 11494630. DOI: 10.1177/03000605241286762.


Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment.

Bonilla M, Radyk M, Perricone M, Elhossiny A, Harold A, Medina-Cabrera P JCI Insight. 2024; 9(18).

PMID: 39315547 PMC: 11457849. DOI: 10.1172/jci.insight.180114.


Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients.

Almeida B, Dias T, Cruz P, Sousa-Pimenta M, Teixeira A, Pereira C Vaccines (Basel). 2024; 12(8).

PMID: 39203974 PMC: 11359428. DOI: 10.3390/vaccines12080848.


References
1.
Lin Y, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R . A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol. 2010; 11(7):635-43. PMC: 2896911. DOI: 10.1038/ni.1891. View

2.
Ouyang W, Liao W, Luo C, Yin N, Huse M, Kim M . Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature. 2012; 491(7425):554-9. PMC: 3771531. DOI: 10.1038/nature11581. View

3.
Calnan D, Brunet A . The FoxO code. Oncogene. 2008; 27(16):2276-88. DOI: 10.1038/onc.2008.21. View

4.
Lam E, Francis R, Petkovic M . FOXO transcription factors: key regulators of cell fate. Biochem Soc Trans. 2006; 34(Pt 5):722-6. DOI: 10.1042/BST0340722. View

5.
Chung S, Ranjan R, Lee Y, Park G, Karpurapu M, Deng J . Distinct role of FoxO1 in M-CSF- and GM-CSF-differentiated macrophages contributes LPS-mediated IL-10: implication in hyperglycemia. J Leukoc Biol. 2014; 97(2):327-39. PMC: 4304426. DOI: 10.1189/jlb.3A0514-251R. View